{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T21:42:34Z","timestamp":1766266954039},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2009,6,23]],"date-time":"2009-06-23T00:00:00Z","timestamp":1245715200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1007\/s00403-009-0973-3","type":"journal-article","created":{"date-parts":[[2009,6,22]],"date-time":"2009-06-22T06:28:18Z","timestamp":1245652098000},"page":"131-137","source":"Crossref","is-referenced-by-count":20,"title":["Time-kinetic study of repigmentation in vitiligo patients by tacrolimus or pimecrolimus"],"prefix":"10.1007","volume":"302","author":[{"given":"L. J.","family":"Lubaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Ghanem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Vereecken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Fouty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Benammar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Vadoud-Seyedi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. L.","family":"Dell\u2019Anna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Briganti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Picardo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Heenen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,6,23]]},"reference":[{"key":"973_CR1","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1600-0749.2004.00149.x","volume":"17","author":"D Agrawal","year":"2004","unstructured":"Agrawal D, Shajil EM, Marfatia YS, Begum R (2004) Study on the antioxidant status of vitiligo patients of different age groups in Baroda. Pigment Cell Res 17:289\u2013294","journal-title":"Pigment Cell Res"},{"key":"973_CR2","first-page":"24","volume":"12","author":"M Akyol","year":"2002","unstructured":"Akyol M, Celik VK, Ozcelik S, Polat M, Marufihah M, Atalay A (2002) The effects of vitamin E on the skin lipid peroxidation and the clinical improvement in vitiligo patients treated with PUVA. Eur J Dermatol 12:24\u201326","journal-title":"Eur J Dermatol"},{"key":"973_CR3","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0190-9622(98)70541-9","volume":"38","author":"S Alaiti","year":"1998","unstructured":"Alaiti S, Kang S, Fiedler VC et al (1998) Tacrolimus (FK506) ointment for atopic dermatitis: a phase I study in adults and children. J Am Acad Dermatol 38:69\u201376","journal-title":"J Am Acad Dermatol"},{"issue":"Suppl 70","key":"973_CR4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2133.2004.06269.x","volume":"151","author":"A Alomar","year":"2004","unstructured":"Alomar A, Berth-Jones J, Bos JD et al (2004) The role of topical calcineurin inhibitors in atopic dermatitis. Br J Dermatol 151(Suppl 70):3\u201327","journal-title":"Br J Dermatol"},{"key":"973_CR5","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1006\/abio.1996.0292","volume":"239","author":"IF Benzie","year":"1996","unstructured":"Benzie IF, Strani JJ (1996) The ferric reducing ability of plasma (FRAP) as a measure of \u201cantioxidant power\u201d: the FRAP assay. Anal Biochem 239:70\u201376","journal-title":"Anal Biochem"},{"key":"973_CR6","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ijpharm.2003.07.013","volume":"269","author":"A Billich","year":"2004","unstructured":"Billich A, Aschauer H, Aszodi A, Stuetz A (2004) Percutaneous absorption of drugs used in atopic eczema: pimecrolimus permeates less through skin than corticosteroids and tacrolimus. Int J Pharm 269:29\u201335","journal-title":"Int J Pharm"},{"key":"973_CR7","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1365-2133.1976.tb04370.x","volume":"94","author":"JS Comaish","year":"1976","unstructured":"Comaish JS, Greener JS (1976) The inhibiting effect of soft paraffin on the Kobner response in psoriasis. Br J Dermatol 94:195\u2013200","journal-title":"Br J Dermatol"},{"key":"973_CR8","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1046\/j.0022-202x.2001.01459.x","volume":"117","author":"ML Dell\u2019Anna","year":"2001","unstructured":"Dell\u2019Anna ML, Maresca V, Briganti S, Camera E, Falchi M, Picardo M (2001) Mitochondrial impairment in peripheral blood mononuclear cells during the active phase of vitiligo. J Invest Dermatol 117:908\u2013913","journal-title":"J Invest Dermatol"},{"key":"973_CR9","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1034\/j.1600-0749.2003.00087.x","volume":"16","author":"ML Dell\u2019Anna","year":"2003","unstructured":"Dell\u2019Anna ML, Urbanelli S, Mastrofrancesco A et al (2003) Alterations of mitochondria in peripheral blood mononuclear cells of vitiligo patients. Pigment Cell Res 16:553\u2013559","journal-title":"Pigment Cell Res"},{"key":"973_CR10","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S0190-9622(96)90691-X","volume":"35","author":"LA Drake","year":"1996","unstructured":"Drake LA, Dinehart SM, Farmer ER et al (1996) Guidelines of care for vitiligo. J Am Acad Dermatol 35:620\u2013626","journal-title":"J Am Acad Dermatol"},{"key":"973_CR11","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1254\/jphs.FP0060605","volume":"102","author":"B Gabryel","year":"2006","unstructured":"Gabryel B, Chalimoniuk M, Stolecka A, Waniek K, Langfort J, Malecki A (2006) Inhibition of arachidonic acid release by cytosolic phospholipase A2 is involved in the antiapoptotic effect of FK506 and cyclosporin a on astrocytes exposed to simulated ischemia in vitro. J Pharmacol Sci 102:77\u201387","journal-title":"J Pharmacol Sci"},{"key":"973_CR12","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1067\/mjd.2002.126250","volume":"47","author":"PE Grimes","year":"2002","unstructured":"Grimes PE, Soriano T, Dytoc MT (2002) Topical tacrolimus for repigmentation of vitiligo. J Am Acad Dermatol 47:789\u2013791","journal-title":"J Am Acad Dermatol"},{"key":"973_CR13","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1515\/CCLM.2002.115","volume":"40","author":"L Iamele","year":"2002","unstructured":"Iamele L, Fiocchi R, Vernocchi A (2002) Evaluation of an automated spectrophotometric assay for reactive oxygen metabolites in serum. Clin Chem Lab Med 40:673\u2013676","journal-title":"Clin Chem Lab Med"},{"key":"973_CR14","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/j.1365-2230.2004.01632.x","volume":"29","author":"AJ Kanwar","year":"2004","unstructured":"Kanwar AJ, Dogra S, Parsad D (2004) Topical tacrolimus for the treatment of childhood vitiligo in Asians. Clin Exp Dermatol 29:589\u2013592","journal-title":"Clin Exp Dermatol"},{"issue":"1","key":"973_CR15","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1254\/jphs.FP0061181","volume":"103","author":"S Kato","year":"2007","unstructured":"Kato S, Nishio H, Ogura M, Takeuchi K (2007) Tacrolimus (FK506), an immunosuppressive agent, prevents indomethacin induced small intestinal ulceration in the rat: inhibition of inducible nitric oxide synthase expression. J Pharmacol Sci 103(1):40\u201347","journal-title":"J Pharmacol Sci"},{"key":"973_CR16","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/j.1365-2230.2004.01524.x","volume":"29","author":"R Koca","year":"2004","unstructured":"Koca R, Armutcu F, Altinyazar HC, Gurel A (2004) Oxidant-antioxidant enzymes and lipid peroxidation in generalized vitiligo. Clin Exp Dermatol 29:406\u2013409","journal-title":"Clin Exp Dermatol"},{"key":"973_CR17","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/j.1365-2133.2005.06739.x","volume":"153","author":"C-CE Lan","year":"2005","unstructured":"Lan C-CE, Chen G-S, Chiou M-H, Wu C-S, Chang C-H, Yu H-S (2005) FK506 promotes melanocyte and melanoblast growth and creates a favourable milieu for cell migration via keratinocytes: possible mechanisms of how tacrolimus ointment induces repigmentation in patients with vitiligo. Br J Dermatol 153:498\u2013505","journal-title":"Br J Dermatol"},{"key":"973_CR18","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1111\/j.0022-202X.2005.23667.x","volume":"124","author":"AY Lee","year":"2005","unstructured":"Lee AY, Kim NH, Choi WI, Youm YH (2005) Less keratinocyte-derived factors related to more keratinocyte apoptosis in depigmented than normally pigmented suction-blistered epidermis may cause passive melanocyte death in vitiligo. J Invest Dermatol 124:976\u2013983","journal-title":"J Invest Dermatol"},{"key":"973_CR19","first-page":"618","volume":"12","author":"AM Marsland","year":"2002","unstructured":"Marsland AM, Griffiths CEM (2002) The macrolide immunosuppressants in dermatology: mechanisms of action. Eur J Dermatol 12:618\u2013622","journal-title":"Eur J Dermatol"},{"key":"973_CR20","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1159\/000073099","volume":"207","author":"FA Mayoral","year":"2003","unstructured":"Mayoral FA, Gonzalez C, Shah NS, Arciniegas C (2003) Repigmentation of vitiligo with pimecrolimus cream: a case report. Dermatology 207:322\u2013323","journal-title":"Dermatology"},{"key":"973_CR21","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1067\/mjd.2002.120942","volume":"46","author":"P Nghiem","year":"2002","unstructured":"Nghiem P, Pearson G, Langley RG (2002) Tacrolimus and pimecrolimus: from clever prokaryotes to inhibiting calcineurin, treating atopic dermatitis. J Am Acad Dermatol 46:228\u2013241","journal-title":"J Am Acad Dermatol"},{"key":"973_CR22","first-page":"1532","volume":"134","author":"MD Njoo","year":"1998","unstructured":"Njoo MD, Spuls PI, Bos JD, Westerhof W, Bossuyt PM (1998) Nonsurgical repigmentation therapies in vitiligo. Meta-analysis of the literature. Arch Dermatol 134:1532\u20131540","journal-title":"Arch Dermatol"},{"key":"973_CR23","unstructured":"Nordlund JJ, Ortonne J-P (1998) Vitiligo vulgaris. In: Nordlund JJ, Boissy RE, Hearing VJ, King RA, Ortonne J-P (eds) The pigmentary system. Physiology and pathophysiology, 1st edn. Oxford University Press, Oxford, pp 513\u2013531"},{"key":"973_CR24","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1046\/j.0022-202X.2003.22110.x","volume":"122","author":"N Otberg","year":"2004","unstructured":"Otberg N, Richter H, Schaefer H, Blume-Peytavi U, Sterry W, Lademann J (2004) Variations of hair follicle size and distribution in different body sites. J Invest Dermatol 122:14\u201319","journal-title":"J Invest Dermatol"},{"key":"973_CR25","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1067\/mjd.2001.109813","volume":"44","author":"A Paller","year":"2001","unstructured":"Paller A, Eichenfield LF, Leung DYM, Appel M (2001) A 12\u00a0week study of tacrolimus ointment for the treatment of atopic dermatitis in pediatric patients. J Am Acad Dermatol 44:47\u201357","journal-title":"J Am Acad Dermatol"},{"key":"973_CR26","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0923-1811(91)90064-5","volume":"2","author":"S Passi","year":"1991","unstructured":"Passi S, Morrone A, Picardo M, De Luca C, Ippolito F (1991) Blood level of vitamin E, polyunsatured fatty acids of phospholipids, lipoperoxides and glutathione peroxidase activity in patients with seborrheic dermatitis. J Dermatol Sci 2:171\u2013178","journal-title":"J Dermatol Sci"},{"issue":"6","key":"973_CR27","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/S1567-5769(01)00059-5","volume":"1","author":"S Sakuma","year":"2001","unstructured":"Sakuma S, Higashi Y, Sato N, Sasakawa T, Sengoku T, Ohkubo Y, Amaya T, Goto T (2001) Tacrolimus suppressed the production of cytokines involved in atopic dermatitis by direct stimulation of human PBMC system (comparison with steroids). Int Immunopharmacol 1(6):1219\u20131226","journal-title":"Int Immunopharmacol"},{"issue":"Suppl 3","key":"973_CR28","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s10227-004-0803-3","volume":"8","author":"DN Sauder","year":"2004","unstructured":"Sauder DN (2004) Mechanism of action and emerging role of immune response modifier therapy in dermatologic conditions. J Cutan Med Surg 8(Suppl 3):3\u201312","journal-title":"J Cutan Med Surg"},{"key":"973_CR29","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1038\/sj.jid.5700257","volume":"126","author":"KU Schallreuter","year":"2006","unstructured":"Schallreuter KU, Chiuchiarelli G, Cemeli E et al (2006) Estrogens can contribute to hydrogen peroxide generation and quinone-mediated DNA damage in peripheral blood lymphocytes from patients with vitiligo. J Invest Dermatol 126:1036\u20131042","journal-title":"J Invest Dermatol"},{"key":"973_CR30","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1159\/000065845","volume":"205","author":"DA Smith","year":"2002","unstructured":"Smith DA, Tofte SJ, Hanifin JM (2002) Repigmentation of vitiligo with topical tacrolimus. Dermatology 205:301\u2013303","journal-title":"Dermatology"},{"key":"973_CR31","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0006-8993(00)02851-1","volume":"889","author":"K Tanaka","year":"2001","unstructured":"Tanaka K, Fujita N, Yoshioka M, Ogawa N (2001) Immunosuppressive and non-immunosuppressive immunophilin ligands improve H2O2-induced cell damage by increasing glutathione levels in NG108-15 cells. Brain Res 889:225\u2013228","journal-title":"Brain Res"},{"key":"973_CR32","first-page":"158","volume":"71","author":"EA Tanghetti","year":"2003","unstructured":"Tanghetti EA (2003) Tacrolimus ointment 0.1% produces repigmentation in patients with vitiligo: results of a prospective patient series. Cutis 71:158\u2013162","journal-title":"Cutis"},{"key":"973_CR33","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1001\/archderm.139.5.571","volume":"139","author":"LB Travis","year":"2003","unstructured":"Travis LB, Weinberg JM, Silverberg NB (2003) Successful treatment of vitiligo with 0.1% tacrolimus ointment. Arch Dermatol 139:571\u2013574","journal-title":"Arch Dermatol"},{"issue":"1","key":"973_CR34","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/09546630601121037","volume":"18","author":"EJ Leent Van","year":"2007","unstructured":"Van Leent EJ, De Vries HJ, Ebelin ME, Burtin P, Scott G, Bos JD (2007) Blood concentrations of pimecrolimus in adult patients with atopic dermatitis following intermittent administration of pimecrolimus cream 1% (Elidel) for up to 1\u00a0year. J Dermatol Treat 18(1):19\u201322","journal-title":"J Dermatol Treat"},{"key":"973_CR35","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s004030050446","volume":"291","author":"DC Whiteman","year":"1999","unstructured":"Whiteman DC, Parsons PG, Green AC (1999) Determinants of melanocyte density in adult human skin. Arch Dermatol Res 291:511\u2013516","journal-title":"Arch Dermatol Res"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-009-0973-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00403-009-0973-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-009-0973-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T13:37:41Z","timestamp":1559050661000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00403-009-0973-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6,23]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["973"],"URL":"https:\/\/doi.org\/10.1007\/s00403-009-0973-3","relation":{},"ISSN":["0340-3696","1432-069X"],"issn-type":[{"value":"0340-3696","type":"print"},{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,6,23]]}}}